Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Mar 27, 2015; 7(3): 575-582
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.575
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.575
Role of diet on non-alcoholic fatty liver disease: An updated narrative review
Dimitrios Papandreou, Department of Natural Science and Public Health, CSSH, Zayed University, Abu Dhabi 144534, United Arab Emirates
Eleni Andreou, Department of Life and Health Science, University of Nicosia, Nicosia 1700, Cyprus
Author contributions: Both authors contributed to this manuscript.
Conflict-of-interest: None of the authors have any conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dimitrios Papandreou, PhD, MEd, MS, RD, Associate Professor of Nutrition, Department of Natural Science and Public Health, CSSH, Zayed University, Khalifa B City, Abu Dhabi 144534, United Arab Emirates. papandreoudimitrios@yahoo.gr
Telephone: +971-2-5993677
Received: August 28, 2014
Peer-review started: August 30, 2014
First decision: November 24, 2014
Revised: December 19, 2014
Accepted: December 29, 2014
Article in press: December 29, 2014
Published online: March 27, 2015
Peer-review started: August 30, 2014
First decision: November 24, 2014
Revised: December 19, 2014
Accepted: December 29, 2014
Article in press: December 29, 2014
Published online: March 27, 2015
Core Tip
Core tip: The beneficial effects of weight loss and exercise have been well documented by many authors in reducing the steatosis, inflammation and fibrosis. Vitamin E can also be used with safety in adults only with biopsy proven non alcoholic steatohepatitis. Consumption of high fructose syrup to the development of non-alcoholic fatty liver disease is still under debate. The data for vitamin C shows no clear effect while the supplementation of n-3 fatty acids and probiotics is still conflicting but shows promise.